 |
 |
 |
|
Comparing adherence to HIV Pre-Exposure Prophylaxis (PrEP) among new, male PrEP users initiating F/TAF vs. F/TDF
|
|
|
IAS 2021 July 18-22
Presenter: Laura Rusie
Authors: N. Sacks (1 ), B. Healey (1 ), L. Rusie * (2), M. Pyra (2), D. Mezzio (3), J. Gruber (3)
Institutions: (1) Precision HEOR, Boston, United States, (2) Howard Brown Health, Chicago, United States, (3) Gilead Science, Foster City, United States





|
|
|
 |
 |
|
|